The ability of the mouse lymphoma TK assay to detect aneugens

Mutagenesis

Volumn 26, Issue 6, 2011, Pages 771-781

  Fellows, Michael D ^a   Doherty, Ann T ^a   Priestley, Catherine C ^a   Howarth, Victoria ^a   O'Donovan, Michael R ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUGEN; CARBENDAZIM; CHLORAL HYDRATE; COLCHICINE; DIAZEPAM; ECONAZOLE; NOSCAPINE; PACLITAXEL; THYMIDINE KINASE; TRIFLURIDINE;

ANEUGENICITY; ANIMAL CELL; ANIMAL CELL CULTURE; CANCER CELL CULTURE; CELL CLONE; CELL MUTANT; CENTROMERE; CHROMOSOME 11; CHROMOSOME SIZE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE LOCUS; HETEROZYGOSITY LOSS; LYMPHOMA CELL; MOUSE; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL;

ANEUGENS; ANIMALS; CELL LINE, TUMOR; CENTROMERE; CHROMOSOMES, MAMMALIAN; ENZYME ASSAYS; GENE DOSAGE; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LOSS OF HETEROZYGOSITY; LYMPHOMA; MICE; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; THYMIDINE KINASE;

EID: 80455149690     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger045     Document Type: Conference Paper

References (40)

1. Aardema, M. J., Albertin, S., Arni, P., Henderson, L.M., Kirsch-Volders, M., Mackay, J. M., Sarrif, A. M., Stringer, D. A. and Taalman, R. D. (1998) Aneuploidy: A report of an ECETOC task force. Mutat. Res., 410, 3-79.
2. Pacchierotti, F. and Ranaldi, R. (2006) Mechanisms and risk of chemically induced aneuploidy in mammalian germ cells. Curr. Pharm. Des., 12, 1489-1504.
3. Applegate, M. L., Moore, M. M., Broder, C. B., Burrell, A., Juhn, G., Kasweck, K. L., Lin, P. F., Wadhams, A. and Hozier, J. C. (1990) Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proc. Natl Acad. Sci. U S A, 87, 51-55.
4. ICH Topic S2B. (1997) Genotoxicity: A Standard Battery for Genotoxicity Testing for Pharmaceuticals. http://www.ich.org/fileadmin/Public-Web-Site/ ICH-Products/Guidelines/Safety/S2-R1/Step4/S2B-step-4.pdf (accessed January 14, 2011).
5. Honma, M., Momose, M., Sakamoto, H., Sofuni, T. and Hayashi, M. (2001) Spindle poisons induce allelic loss in mouse lymphoma cells through mitotic non-disjunction. Mutat. Res., 493, 101-114.
6. O'Donovan, M. R., Clare, M. G., Clements, J., Fellows, M. and Oliver, J. (1999) Are aneugens mutagenic in the mouse lymphoma TK assay? Abstracts of the United Kingdom environmental mutagen society 23(rd) annual general meeting, June 23-25, university of Ulster, Coleraine, Northern Ireland, UK. Mutagenesis, 14, 639-656.
7. Wang, J., Sawyer, J. R., Chen, L., Chen, T., Honma, M., Mei, N. and Moore, M. M. (2009) The mouse lymphoma assay detects recombination, deletion, and aneuploidy. Toxicol. Sci., 109, 96-105.
8. Evans, H. H., Mencl, J., Horng, M.-F., Ricanati, M., Sanchez, C. and Hozier, J. (1986) Locus specificity in the mutability of L5178Y mouse lymphoma cells: The role of multilocus lesions. Proc. Natl Acad. Sci. U S A, 83, 4379-4383.
9. Liechty, M. C., Scalzi, J. M., Sims, K. R., Crosby, H., Jr., Spencer, D. L., Davis, L. M., Caspary, W. J. and Hozier, J. C. (1998) Analysis of large and small colony L5178Y tk-/- mouse lymphoma mutants by loss of heterozygosity (LOH) and by whole chromosome 11 painting: Detection of recombination. Mutagenesis, 13, 461-474.
10. Fellows, M., Doherty, A., Hayes, J., Thompson, A. and O'Donovan, M. R. (2005) In the mouse lymphoma Tk assay, are Tk/mutant clones formed following treatment with the aneugen Carbendazim monosomic for chromosome 11? Abstracts of the 28th Annual Meeting of the United Kingdom Environmental Mutagen Society, August 3-5, at the University of Bradford, UK. Mutagenesis, 20, 469-488.
11. de Nooij-van Dalen, A. G., van Buuren-van Seggelen, V. H. A., Lohman, P. H. M. and Giphart-Gassle, M. (1998) Chromosome loss with concomitant duplication and recombination both contribute most to loss of heterozygosity in vitro. Genes Chromosomes Cancer, 21, 30-38.
12. Wijnhoven, S. W., Sonneveld, E., Kool, H. J., van Teijlingen, C. M. and Vrieling, H. (2003) Chemical carcinogens induce varying patterns of LOH in mouse T-lymphocytes. Carcinogenesis, 24, 139-144.
13. Kirsch-Volders, M., Vanhauwaert, A., Eichenlaub-Ritter, U. and Decordier, I. (2003) Indirect mechanisms of genotoxicity. Toxicol. Lett., 140-141, 63-74.
14. Schiff, P. B., Fant, J. and Horwitz, S. B. (1979) Promotion of microtubule assembly in vitro by taxol. Nature, 277, 665-667.
15. Faust, J. B. and Salmon, A. (2003) Evidence on the Carcinogenicty of Chloral hydrate (2003 Update). Reproductive and Cancer Hazard Assessment Section, Office of environmental health Hazard assessment, California environmental Protection Agency, http://oehha.ca.gov/prop65/ hazardident/pdf-zip/chloralhyDhid.pdf. (accessed March 22, 2011).
16. Diguiseppi, J., Gawdi, G. M. and Herman, B. (1987) Chloral hydrate disrupts mitosis by increasing intracellular free calcium. J. Cell Sci., 88, 603-612.
17. Schuler, M., Muehlbauer, P., Guzzie, P. and Eastmond, D. A. (1999) Noscapine hydrochloride disrupts the mitotic spindle in mammalian cells and induces aneuploidy as well as polyploidy in cultured human lymphocytes. Mutagenesis, 14, 51-56.
18. Aneja, R., Dhiman, N., Idnani, J., Awasthi, A., Arora, S. K., Chandra, R. and Joshi, H. C. (2007) Preclinical pharmacokinetics of bioavailability of noscapine, a tubulin-binding anticancer agent. Cancer Chemother. Pharmacol., 60, 831-839.
19. Andersson, L. C., Lehto, V. P., Stenman, S., Badley, R. A. and Virtanen, I. (1981) Diazepam induces mitotic arrest at prometaphase by inhibiting centriolar separation. Nature, 291, 247-248.
20. Parry, J. M. and Sors, A. (1993) The detection and assessment of aneugenic potential of environmental chemicals: The European Community Aneuploidy Project. Mutat. Res., 287, 3-15.
21. Wallin, M., Friden, B. and Billger, M. (1988) Studies of the interaction of chemicals with microtubule assembly in vitro can be used as an assay for detection of cytotoxic chemicals and possible inducers of aneuploidy. Mutat. Res., 201, 303-311.
22. Jordan, M. A. and Wilson, L. (2004) Microtubules as a target for anticancer drugs. Nat. Rev. Cancer, 4, 253-265.
23. Gudi, R., Xu, J. and Thilagar, A. (1992) Assessment of the in vivo aneuploidy/micronucleus assay in mouse bone marrow cells with 16 chemicals. Environ. Mol. Mutagen., 20, 106-116.
24. Hozier, J., Sawyer, J., Moore, M. M., Howard, B. and Clive, D. (1981) Cytogenetic analysis of the L5178Y/TK+/- leads to TK-/- mouse lymphoma mutagenesis assay system. Mutat. Res., 84, 169-181.
25. Sawyer, J., Moore, M. M., Clive, C. and Hozier, J. (1985) Cytogenetic characterization of the L5178Y TK+/-3.7.2C mouse lymphoma cell line. Mutat. Res., 147, 243-253.
26. Clive, D., Flamm, W. G., Machesko, M. R. and Bernheim, N. J. (1972) A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat. Res., 16, 77-87.
27. Clive, D. and Spector, J. F. S. (1975) Laboratory procedures for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutat. Res., 31, 17-29.
28. Clements, J. (2000) The mouse lymphoma assay. Mutat. Res., 455, 97-110.
29. Honma, M., Zhang, L. S., Sakamoto, H., Ozaki, M., Takeshita, K., Mamose, M., Hayashi, M. and Sofuni, T. (1999) The need for long-term treatment in the mouse lymphoma assay. Mutagenesis, 14, 23-29.
30. Moore, M. M., Honma, M., Clements, J. et al. (2006) Mouse lymphoma thymidine kinase gene mutation assay: Follow-up meeting of the International Workshop on Genotoxicity Testing-Aberdeen, Scotland, 2003-assay acceptance criteria, positive controls, and data evaluation. Environ. Mol. Mutagen., 47, 1-5.
31. Singh, S. P., Chen, T., Chen, L., Me, N., McLain, E., Samokyszyn, V., Thaden, J. J., Moore, M. M. and Zimniak, P. (2005) Mutagenic effects of 4- hydroxynonenal triacetate, a chemically protected form of the lipid peroxidation product 4-hydroxynonenal, as assayed in L5178Y/Tk+/- mouse lymphoma cells. J Pharmacol. Exp. Ther., 313, 855-861.
32. NCBI. (2008) Primer-BLAST [online]. http://www.ncbi.nlm.nih.gov/tools/ primer-blast/ (accessed March 22, 2011).
33. Sawyer, J. R., Binz, R. L., Wang, J. and Moore, M. M. (2006) Multicolor spectral karyotyping of the L5178Y Tk+/- -3.7.2C mouse lymphoma cell line. Environ. Mol. Mutagen., 47, 127-131.
34. Liechty, M. C., Hassanpour, Z., Hozier, J. C. and Clive, D. (1994) Use of microsatellite DNA polymorphisms on mouse chromosome 11 for in vitro analysis of thymidine kinase gene mutations. Mutagenesis, 9, 423-427.
35. Liechty, M. C., Crosby, H., Jr., Murthy, A., Davis, L. M., Caspary, W. J. and Hozier, J. C. (1996) Identification of a heteromorphic microsatellite within the thymidine kinase gene in L5178Y mouse lymphoma cells. Mutat. Res., 371, 265-271.
36. Harrington-Brock, K., Doerr, C. L. and Moore, M. M. (1998) Mutagenicity of three disinfection by-products: Di- and trichloroacetic acid and chloral hydrate in L5178Y / TK+/- 3.7.2C mouse lymphoma cells. Mutat. Res., 413, 265-276.
37. OECD Test Guideline 487. http://www.oecd-ilibrary.org/docserver/ download/fulltext/9748701e.pdf?expires51305722935&id5id&accname5 freeContent&checksum579BAA1F9D18C26EED3D78AE07B3107E2 (accessed May 20, 2011).
38. Fellows, M. D. and O'Donovan, M. R. (2010) Etoposide, cadmium chloride, benzo[a]pyrene, cyclophosphamide and colchicine tested in the in vitro mammalian cell micronucleus test (MNvit) in the presence and absence of cytokinesis block using L5178Y mouse lymphoma cells and 2- aminoanthracene tested in MNvit in the absence of cytokinesis block using TK6 cells at AstraZeneca UK, in support of OECD draft Test Guideline 487. Mutat. Res., 702, 163-170.
39. Kirchner. S. and Zeller, A. (2010) Comparison of different cytotoxicity measures for the in vitro micronucleus test (MNVit) in L5178Y tk+/ cells: Summary of 4 compounds (Mitomycin C, Cyclophosphamide, Colchicine and Diethylstilboestrol) with clastogenic and aneugenic mode of action. Mutat. Res., 702, 193-198.
40. Lorge, E. (2010) Comparison of different cytotoxicity measurements for the in vitro micronucleus assay using L5178Y and TK6 cells in support of OECD draft Test Guideline 487. Mutat. Res., 702, 199-207.